Jonathan Alspaugh is CFO at Aeglea BioTherapeutics, Inc. (AGLE). They have made 3 open-market trades across 1 company since 2021, most recently 2022-03-11.
CIK 0001868112
3 open-market purchases totalling $667K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AGLE | 165,372 | $2.0M |
Shares reported on the most recent Form 4, priced at the 2022-03-15 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.